Citation Impact
Citing Papers
Comprehensive genomic characterization of head and neck squamous cell carcinomas
2015 StandoutNature
Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions
2021 StandoutNobel
Functional Interaction between SEL-10, an F-box Protein, and the Nuclear Form of Activated Notch1 Receptor
2001 StandoutNobel
Skin cancer in renal transplant recipients
1989
Persistence of human papillomavirus (HPV) infections preceding cervical carcinoma
1996
Regulation of p53 stability by Mdm2
1997 StandoutNature
Clinical utility of telomerase in cancer
2002
The human papillomavirus E7 protein as a transforming and transactivating factor
1993
A novel cis-stimulatory element maps to the 5' portion of the human papillomavirus type 18 upstream regulatory region and is functionally dependent on a sequence-aberrant Sp1 binding site
1993
Papillomavirus infections — a major cause of human cancers
1996 StandoutNobel
In situ hybridization detection of single-copy human papillomavirus on isolated cells, using a catalyzed signal amplification system: Genpoint?
2001
Immortalization and Transformation of Human Cells by Human Papillomavirus
1994
Association of human papillomavirus with penile carcinoma: A study using polymerase chain reaction and in situ hybridization
1991
Identification of a Neural Stem Cell in the Adult Mammalian Central Nervous System
1999 Standout
Papillomaviruses in lesions of the lower genital tract in Israeli patients
1988
Chapter 1: Human Papillomavirus and Cervical Cancer--Burden and Assessment of Causality
2003
The role of human papillomavirus in cervical adenocarcinoma carcinogenesis
2001
Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cervical cancers
1989
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
1993 Standout
Immortalization of primary rat cells by human papillomavirus type 16 subgenomic DNA fragments controlled by the SV40 promoter
1988
Expression of RB and p53 proteins in HPV‐positive and HPV‐negative cervical carcinoma cell lines
1991
Balancing Acts
2004 Standout
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
1990 Standout
Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins.
1994
Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone
1990 Standout
The predominant mRNA class in HPV16‐infected genital neoplasias does not encode the e6 or the E7 protein
1993
Genomic Variation of Human Papillomavirus Type 16 and Risk for High Grade Cervical Intraepithelial Neoplasia
1997
Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
2007 Standout
Activation of human papillomavirus type 18 E6–E7 oncogene expression by transcription factor Sp1
1992
A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1
2011 StandoutNatureNobel
Skin Cancers after Organ Transplantation
2003 Standout
HPV types and cofactors causing cervical cancer in Peru
2001
Development and Assessment of a General Theory of Cervical Carcinogenesis Utilizing a Severe Combined Immunodeficiency Murine–Human Xenograft Model
2000
Ectopic Expression of Nonliganded Retinoic Acid Receptor β Abrogates AP-1 Activity by Selective Degradation of c-Jun in Cervical Carcinoma Cells
2004 StandoutNobel
Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers
2000 Standout
Forging a signature of in vivo senescence
2015
Papillomaviruses and cancer: from basic studies to clinical application
2002 StandoutNobel
Association of oral contraceptive use and human papillomaviruses in invasive cervical cancers
1990
Risk factors for cervical cancer in Colombia and Spain
1992
Expression of human papillomavirus type 16 E7 gene induces DNA synthesis of rat 3Y1 cells
1989
Human papillomavirus type 16 E7 protein expressed in Escherichia coli and monkey COS-1 Cells: Immunofluorescence detection of the nuclear E7 protein
1989
Viral integration and fragile sites in human papillomavirus‐lmmortalized human keratinocyte cell lines
1992
Integration of human papillomavirus type 16 into cellular DNA of cervical carcinoma: Preferential deletion of the E2 gene and invariable retention of the long control region and the E6/E7 open reading frames
1987
Case–Control Study of Human Papillomavirus and Oropharyngeal Cancer
2007 Standout
Glucocorticoid-enhanced neoplastic transformation of human keratinocytes by human papillomavirus type 16 and an activated ras oncogene
1989
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
2010 Standout
Association of human papillomavirus with nasal neoplasia
1993
Determinants of Persistent Detection of Human Papillomavirus DNA in the Uterine Cervix
1996
Transcriptional regulation of the human papillomavirus-16 E6-E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 trans-activator and repressor gene products: implications for cervical carcinogenesis.
1987
The influence of bio-behavioural factors on tumour biology: pathways and mechanisms
2006
Molecular Pathogenesis of Cancer of the Cervix and Its Causation by Specific Human Papillomavirus Types
1994 StandoutNobel
Head and Neck Cancer
1993 Standout
The papillomavirus E6 proteins
1998
Natural History of Cervicovaginal Papillomavirus Infection in Young Women
1998 Standout
Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix
1994 StandoutNobel
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
2000 Standout
Cellular control of human papillomavirus oncogene transcription
1994
Expression of multiple classes of the Nuclear Factor-1 family in the developing human brain: Differential expression of two classes of NF-1 genes
1996
Oral contraceptives and cervical neoplasia
1991
Human papillomavirus type 16 and 18 gene expression in cervical neoplasias
1992
Human papillomavirus DNA in normal, metaplastic, preneoplastic and neoplastic epithelia of the cervix uteri
1988
A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear Receptors
1996 Standout
Detection of human papillomavirus type 57 in a case of inverted nasal papillomatosis in Japan
1995
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
2016 StandoutNature
Papilloma viruses in cancers and papillomas of the aerodigestive tract
1989
Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity
2004
Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein
1988 Standout
p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest
1994 Standout
Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
2003 Standout
Transformation of rat 3Y1 cells by human papillomavirus type‐18 DNA
1988
The Ubiquitin-related BAG-1 Provides a Link between the Molecular Chaperones Hsc70/Hsp70 and the Proteasome
2000
Human Papillomaviruses and cervical Cancer
1997
Cellular transformation by papilomavirus oncorproteins
1993
Head and Neck Cancer
2001 Standout
Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
2007 Standout
Alterations in Notch signaling in neoplastic lesions of the human cervix.
1995
Human Papillomaviruses And Genital Cancer
1987
Human papillomavirus DNA types in squamous cell carcinomas of the head and neck
1991
Head and Neck Cancer
2020 Standout
The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region.
1987
Epidermal growth factor (EGF) elicits down-regulation of human papillomavirus type 16 (HPV-16) E6/E7 mRNA at the transcriptional level in an EGF-stimulated human keratinocyte cell line: functional role of EGF-responsive silencer in the HPV-16 long control region
1991
Repression of the human papillomavirus type 18 enhancer by the cellular transcription factor Oct-1
1991 StandoutNobel
β-Phenylethylamines and the isoquinoline alkaloids
2004
Human papillomavirus type 16 transformation of rat 3Y1 cells.
1987
Molecular analysis of integrated human papillomavirus 16 sequences in the cervical cancer cell line SiHa
1987
A specific 15-bp TATA box promoter element is required for expression of a herpes simplex virus type 1 late gene.
1988
Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region
1993
A keratinocyte-specific transcription factor, KRF-1, interacts with AP-1 to activate expression of human papillomavirus type 18 in squamous epithelial cells.
1991
Amplification of the integrated viral transforming genes of human papillomavirus 18 and its 5'-flanking cellular sequence located near the myc protooncogene in HeLa cells.
1989
Genes and pathways downstream of telomerase in melanoma metastasis
2006 StandoutNobel
Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms
1989
Thiouracil Cross-Linking Mass Spectrometry: a Cell-Based Method To Identify Host Factors Involved in Viral Amplification
2013
Neuronal Expression of the 5HT3Serotonin Receptor Gene Requires Nuclear Factor 1 Complexes
1998 StandoutNobel
Characterization of a novel human papillomavirus DNA in the cervical carcinoma cell line ME180
1991 StandoutNobel
Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas.
1987
Translational pathophysiology: a novel molecular mechanism of human disease
2000
Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines
1987
Integration and Transcription of Human Papillomavirus Type 16 and 18 Sequences in Cell Lines Derived from Cervical Carcinomas
1987
HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes.
1989 Standout
Inducible and constitutive enhancer domains in the noncoding region of human papillomavirus type 18
1988
The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element
1990
Human papillomavirus type 16 transformation of primary human embryonic fibroblasts requires expression of open reading frames E6 and E7
1989
Molecular Chaperones in the Cytosol: from Nascent Chain to Folded Protein
2002 StandoutScience
Human Papillomavirus and Cervical Cancer
2003 Standout
Functional significance of sequence variation in the E2 gene and the long control region of human papillomavirus type 16.
1999
Activation of human papillomavirus type 18 gene expression by herpes simplex virus type 1 viral transactivators and a phorbol ester
1989
Transcriptional Control and Cell Type Specificity of HPV Gene Expression
1994
Self-Assembled Organic Monolayers: Model Systems for Studying Adsorption of Proteins at Aurfaces
1991 StandoutScience
Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements
1987 Standout
HUMAN PAPILLOMAVIRUS INFECTIONS IN WOMEN WITH AND WITHOUT ABNORMAL CERVICAL CYTOLOGY
1987 StandoutNobel
Polyimides
1991 Standout
Interplay of viral and cellular proteins along the long control region of human papillomavirus type 18
1988
The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes
1989
Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes.
1986
Nucleotide sequences of cDNAs for human papillomavirus type 18 transcripts in HeLa cells
1988
Viruses in Human Cancers
1991 StandoutScienceNobel
Increased sensitivity of human keratinocytes immortalized by human papillomavirus type 16 DNA to growth control by retinoids.
1992
Regulation of cytomegalovirus gene expression: alpha and beta promoters are trans activated by viral functions in permissive human fibroblasts
1985
Deletion and translocation of chromosome 11q13 sequences in cervical carcinoma cell lines.
1995
Identification of early proteins of the human papilloma viruses type 16 (HPV 16) and type 18 (HPV 18) in cervical carcinoma cells.
1987
The human papillomavirus type 16 E7 protein complements adenovirus type 5 E1A amino-terminus-dependent transactivation of adenovirus type 5 early genes and increases ATF and Oct-1 DNA binding activity
1996
Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells.
1991 StandoutNobel
Isolation of a novel human papillomavirus (type 51) from a cervical condyloma
1988
Notch Signaling: Cell Fate Control and Signal Integration in Development
1999 StandoutScience
Progesterone and glucocorticoid response elements occur in the long control regions of several human papillomaviruses involved in anogenital neoplasia
1989
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
2002 StandoutNobel
Nitrated Confined Imidodiphosphates Enable a Catalytic Asymmetric Oxa-Pictet–Spengler Reaction
2016 StandoutNobel
Transcriptional trans-activation by the human papillomavirus type 16 E2 gene product
1987
Characterization of the complete RhPV 1 genomic sequence and an integration locus from a metastatic tumor
1991
Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
1990 StandoutScience
Metal Ion — Hydrophobic, Thiophilic and II‐Electron Governed Interactions and their Application to Salt‐Promoted Protein Adsorption Chromatography
1987
Characterization of a transcriptional promoter of human papillomavirus 18 and modulation of its expression by simian virus 40 and adenovirus early antigens
1987
Identification of a negative regulatory domain in the human papillomavirus type 18 promoter: interaction with the transcriptional repressor YY1.
1992 StandoutNobel
Characterization of a cell type-specific enhancer found in the human papilloma virus type 18 genome.
1987
The Human Papilloma Virus-16 E7 Oncoprotein Is Able to Bind to the Retinoblastoma Gene Product
1989 StandoutScience
Human papillomavirus type 16 open reading frame E7 encodes a transforming gene for rat 3Y1 cells
1988
Cloning of monomeric human papillomavirus type 16 DNA integrated within cell DNA from a cervical carcinoma
1986
Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells.
1988
Works of Alan Pater being referenced
Telomerase Activity in Papanicolaou Smear-Negative Exfoliated Cervical Cells and Its Association with Lesions and Oncogenic Human Papillomaviruses
2000
Expression of human papillomavirus types 16 and 18 DNA sequences in cervical carcinoma cell lines
1988
Malignant transformation of HPV 16-immortalized human endocervical cells by cigarette smoke condensate and characterization of multistage carcinogenesis
1996
Cloning and characterization of the human BAG-1 gene promoter: upregulation by tumor-derived p53 mutants
1999
Glucocorticoid-dependent oncogenic transformation by type 16 but not type 11 human papilloma virus DNA
1988 Nature
RU486 inhibits glucocorticoid hormone-dependent oncogenesis by human papillomavirus type 16 DNA
1991
The first 124 nucleotides of the E7 coding sequences of HPV16 can render the HPV11 genome transformation competent
1992
Induction of p16 during immortalization by HPV 16 and 18 and not during malignant transformation
1997
Oncogenic transformation by human papillomavirus type 16 deoxyribonucleic acid in the presence of progesterone or progestins from oral contraceptives
1990
The alkaloid sanguinarine is effective against multidrug resistance in human cervical cells via bimodal cell death
2002
Human BAG-1/RAP46 protein is generated as four isoforms by alternative translation initiation and overexpressed in cancer cells
1998
Effect of Glucocorticoid Hormones on Viral Gene Expression, Growth, and Dysplastic Differentiation in HPV16-Immortalized Ectocervical Cells
1997
Identification and characterization of a JC virus pentanucleotide repeat element binding protein: cellular nucleic acid binding protein
1998
Ubiquitous and cell-type-specific protein interactions with human papillomavirus type 16 and type 18 enhancers
1990
Isolation and characterization of a variant of human papillomavirus type 11 from a nasal inverting (schneiderian) papilloma
1988
Positive control of the herpes simplex virus thymidine kinase gene requires upstream DNA sequences
1983
Human JC virus perfect palindromic nuclear factor 1-binding sequences important for glial cell-specific expression in differentiating embryonal carcinoma cells
1993
Nucleotide 880 splice donor site required for efficient transformation and RNA accumulation by human papillomavirus type 16 E7 gene
1992
Expression of cellular genes in HPV16-immortalized and cigarette smoke condensate-transformed human endocervical cells
1997
Isolation and Characterization of Papillomavirus DNA from Nasal Inverting (Schneiderian) Papillomas
1987
Human papillomavirus types 16 and 18 sequences in early cervical neoplasia
1986
Human papillomavirus 18-immortalized endocervical cells with in vitro cytokeratin expression characteristics of adenocarcinoma.
1994
In vitro and in vivo analysis of cellular origin of cervical squamous metaplasia.
1993
Human papillomavirus type 16 expression in cervical keratinocytes: role of progesterone and glucocorticoid hormones.
1993
Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix
1985
Simultaneous separation of halophilic proteins and nucleic acids after adsorption onto agarose gels
1977
Multiple human papillomavirus type 16 glucocorticoid response elements functional for transformation, transient expression, and DNA-protein interactions
1993